Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BMY - Better Buy: Celgene vs. Gilead Sciences


BMY - Better Buy: Celgene vs. Gilead Sciences

Should you go with the biotech that's going away or the one that's bouncing back? That's pretty much the question for investors when it comes to deciding between Celgene (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD).

Celgene is probably only a few months away from being absorbed by Bristol-Myers Squibb (NYSE: BMY). Gilead appears to be making a comeback after several years of revenue and earnings declines. Which stock is now the better pick for investors?

Image source: Getty Images.

Continue reading

Stock Information

Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com

Menu

BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...